Zobrazeno 1 - 10
of 10 652
pro vyhledávání: '"J, Marek"'
Autor:
Tovian, Steven M. (AUTHOR) s-tovian@northwestern.edu
Publikováno v:
Journal of Personality Assessment. Jul/Aug2024, Vol. 106 Issue 4, p558-560. 3p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Leah Boepple, Ian Cero, Ryan J. Marek, Sandra Coulon, Janet A. Lydecker, Joshua D. Brown, Robert Malcolm, Patrick M. O'Neil
Publikováno v:
Obesity Science & Practice, Vol 5, Iss 6, Pp 548-554 (2019)
Summary Objective Research suggests that individuals seeking weight loss treatment do so for a variety of reasons. Limited work has explored relations of reasons for weight loss to patient characteristics or to weight loss outcomes. The current study
Externí odkaz:
https://doaj.org/article/a8953e5e058f464d8881f8dcf26c8663
Autor:
Ryan J. Marek, Valentina Ivezaj, Manish S. Parikh, Maansi Jayade, Elissa Davila-Shiau, Carlos M. Grilo
Publikováno v:
Surgery for Obesity and Related Diseases. 19:576-584
Autor:
Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif, Gerard J Marek
Publikováno v:
Journal of Psychopharmacology. 37:449-461
Background: Recent increases in opioid use and subsequent opioid use disorder are a major public health crisis in the United States. Aims: This phase 1 randomized, placebo-controlled study investigated the safety, tolerability, and pharmacokinetics (
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 3, Pp 291-301 (2019)
Inhibition of the enzyme 11β‐hydroxysteroid dehydrogenase type 1 (11β‐HSD1) represents a potential mechanism for improving pain conditions. ASP3662 is a potent and selective inhibitor of 11β‐HSD1. Two phase I clinical studies were conducted
Externí odkaz:
https://doaj.org/article/4136bf49b098469fa7b9596299aa65f8
Autor:
Reinhart, Karl-Franz, Illing, Matthias
Publikováno v:
Sensors Update; February 2003, Vol. 12 Issue: 1 p213-230, 18p
Autor:
Janelle N. Dixon, Tonneka M. Caddell, Apryl A. Alexander, Danielle Burchett, Jaime L. Anderson, Ryan J. Marek, David M. Glassmire
Publikováno v:
Law and Human Behavior. 47:292-306
Autor:
Mototsugu Ito, Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh, Paul Blahunka, Jay Erdman, Mohamad Nour Alsharif, Gerard J Marek
Publikováno v:
Journal of Psychopharmacology. 37:144-154
Background: There is an unmet need for therapeutics with greater efficacy and tolerability for the treatment of opioid use disorder (OUD). ASP8062 is a novel compound with positive allosteric modulator activity on the γ-aminobutyric acid type B rece